News in Numbers

Lykos has slashed its workforce by 75% following the US Food and Drug Administration’s refusal to approve its MDMA therapy in PTSD.

As Africa’s Centres for Disease Control and Prevention (CDC) declared a public health emergency amid mpox outbreaks on the continent, Bavarian Nordic has donated 40,000 doses of its vaccine to the agency.

German life science company Evotec has cut 400 jobs as it continues to deal with what is describes as ‘more difficult market environment’.

At its latest polio committee meeting, the World Health Organization announced 12 new cases of wild polio virus have been reported since its last meeting, bringing the 2024 total to 14.

Precigen will reduce its workforce by 20% and pause several programmes to focus on the potential commercialisation of its PRGN-2012 gene therapy for recurrent respiratory papillomatosis.